Isoform E2 of drebrin, an actin-binding protein originally identified in neuronal cells, has recently been identified in diverse non-neuronal cells, mostly in association with cell processes and intercellular junctions. Here, we report on the presence of drebrin in normal human skin, epithelial skin cancers, and cultured keratinocytes. Keratinocytes of normal epidermis contain almost no drebrin but the protein is readily seen in hair follicles. By immunohistochemistry and immunoblot, basal cell carcinomas (BCC) are rich in drebrin, and confocal laser scanning and immunoelectron microscopy show accumulation at adhering junctions, in co-localization with actin and partially with plaque proteins. In squamous cell carcinomas, keratoacanthomas, and in epidermal precancers, drebrin is heterogeneously distributed, appearing as mosaics. Primary keratinocyte cultures contain significant amounts of drebrin enriched at adhering junctions. When epithelium-derived cells devoid of drebrin are transfected with drebrin-enhanced green fluorescent protein, constructs accumulate in the cell periphery, and immunoprecipitation shows complexes with actin. During epidermal growth factor induced formation of cell processes, drebrin retains this junction association, as observed by live cell microscopy. Our results suggest novel functions of drebrin such as an involvement in cell-cell adhesion and tumorigenesis and a potential value in diagnosis of BCC.
Skin carcinomas are the most frequent cancers in the lightskinned population, with an estimated yearly incidence of approximately 100 basal cell carcinomas (BCC) and approximately 20 squamous cell carcinomas (SCC) per 100,000 inhabitants. Important and long-known pathogenetic factors for skin carcinogenesis include ultraviolet (UV) light, radiation, and a diversity of chemical carcinogens. Only recently, molecular pathways leading to development of BCC and SCC have been elucidated. In inherited BCC such as in Gorlin's syndrome and in sporadic BCC, gene mutations of proteins of the Sonic Hedgehog signal transduction pathway have been identified that lead to basaloid hyperproliferations and infiltrative tumors (Hahn et al, 1996 ; for a recent review see, e.g., Cohen, 2003) . In addition, there is increasing evidence that defects in cell-cell adhesion might contribute to skin carcinogenesis. For example, downregulation of E-cadherin, the major transmembrane protein of adhering junctions in epithelial cells, has been reported to correlate with development, progression, and metastasis of several kinds of carcinomas (e.g., Behrens et al, 1989; Shimoyama and Hirohashi, 1991; Moll et al, 1993; Perl et al, 1998; review: Cavallaro and Christofori, 2004) , including SCC of the skin (Llorens et al, 1998; Lozano and Cano, 1998; Wu et al, 2000; Papadavid et al, 2002) . Moreover, b-catenin, a constitutive protein of the cytoplasmic plaque of adhering junctions, is part of the Wnt signaling pathway, a cascade of reactions leading to transcription of target genes for proliferation (recently reviewed by Nelson and Nusse, 2004) . Specifically in the skin, activating mutations of b-catenin cause proliferation of cells of the hair follicle sheath and development of pilomatrixomas (Gat et al, 1998; Chan et al, 1999; Doglioni et al, 2003) , and this protein might also be involved in the formation of BCC (El-Bahrawy et al, 2003) .
In addition to their involvement in tumor development and progression, proteins of intercellular junctions can also serve as cell-type ''markers'' in tumor diagnosis and are thus of particular value in cases of unknown primary tumors and for determination of the degree of differentiation. This has been shown extensively for plaque proteins of desmosomes such as desmoplakin (e.g., Franke et al, 1983; Moll et al, 1986; Jones and Grelling, 1989; review: Garrod, 1995) , the plakophilins (Heid et al, 1994; Mertens et al, 1999) , and the various desmosomal cadherins (Parrish et al, 1986; Nuber et al, 1995; Schä fer et al, 1996 ; for skin tumors see Abbreviations: BCC, basal cell carcinoma; EGF, epidermal growth factor; EGFP, enhanced green fluorescent protein; IRS, inner root sheath; mab, monoclonal antibody; ORS, outer root sheath; PBS, phosphate-buffered saline; RT, room temperature; SCC, squamous cell carcinoma Copyright r 2005 by The Society for Investigative Dermatology, Inc. Krunic et al, 1996; Moll et al, 1997) . Similarly, several celltype-specific components of adhering junctions, notably members of the cadherin and the armadillo families of proteins, have been introduced into pathology (for references, see Mareel et al, 1994; Tsukita et al, 1994; Nakanishi et al, 1997; Hirohashi and Kanai, 2003) .
A protein recently identified at adhering junctions as well as at lamellipodia and elongated cell processes of various cell types is drebrin, an actin-binding protein (Peitsch et al, 1999 (Peitsch et al, , 2001 Keon et al, 2000) . This protein, originally detected in neuronal cells (acronym for developmentally regulated brain protein), can occur in four isoforms, drebrin E1, E2, A, and sA (review: Shirao, 1995) , only one of which, E2, has so far been identified in non-neuronal cells. In neuronal cells, the drebrins appear to be involved in the formation of cell processes and in synaptic plasticity (e.g., Takahashi et al, 2003) . Correspondingly, transfection of the drebrin cDNA can cause formations of long actin-rich protrusions and remodeling of the actin cytoskeleton (e.g., Shirao et al, 1992; Keon et al, 2000) , whereas antisense cDNA results in suppression of neurite outgrowth (Toda et al, 1999) .
In epithelial and endothelial cells, drebrin has been localized primarily to intercellular junctions (Peitsch et al, 1999) , whereas in a series of other cell types, it appears to be accumulated in actin filament-rich cell processes (Peitsch et al, 2001 (Peitsch et al, , 2003 . Drebrin has so far not been detected in the skin and in skin tumors. Moreover, very little is known about its distribution and function in stratified epithelia. Therefore, we have generated a novel monoclonal drebrin antibody that could be used, in combination with other antibodies, to study the distribution of drebrin in normal skin, epithelial skin tumors, and cultured keratinocytes. In addition, we have transfected cells of a related cell type, the vulvar carcinoma line A431 devoid of endogenous drebrin, with cDNA combining drebrin E2 with enhanced green fluorescent protein (EGFP) to allow the study of this protein by immunocytochemistry and live cell microscopy.
Results
Drebrin distribution in normal human skin In previous studies, we had noted drebrin staining along intercellular junctions of certain epithelial and endothelial cell types (Peitsch et al, 1999 (Peitsch et al, , 2003 . But not much was known about drebrin in stratified squamous epithelia, including the epidermis, and tumors derived therefrom. Therefore, examination of the presence, localization, and dynamics of this protein in human skin and related tissues as well as SCC was overdue. As, in our former studies, the only available monoclonal antibody (mab) to drebrin (clone M2F6) had worked well on cultured cells but sometimes showed reactions that were too faint or of dubious significance on tissue sections, we decided to generate a novel mab against drebrin that reliably reacted with all isoforms (mab Mx823; see Materials and Methods). This antibody was used in parallel with the mab M2F6, a guinea-pig antiserum directed against the same peptide (dreb4.1 gp) and two further guinea-pig drebrin antisera (dreb254.2 gp and drebE2/A.2 gp).
Immunostaining on cryostat and paraffin-embedded sections of normal human skin (Fig 1) showed that the epidermis was essentially negative for drebrin ( Fig 1A) . Drebrin was, however, enriched in the ducts of eccrine sweat glands, especially along their cell-cell boundaries (Fig 1B) , whereas sebaceous glands did not display detectable amounts. In addition, intercellular junctions of hair follicles were stained, both in the bulbs (Fig 1C) and, in upper parts, in a layer apparently corresponding to the outer root sheath (ORS; Fig 1D) . As previously reported (Peitsch et al, 1999) , small blood vessels in the dermis were also drebrin-positive (asterisks in Figs 1A and B) . This specific distribution pattern was observed in normal human skin from different parts of the body such as the face, scalp, trunk, and foot sole, and with all the various drebrin antibodies used.
To further specify the localization of drebrin within hair follicles, double-label confocal microscopy was performed on cryostat sections of scalp skin, using drebrin antibodies in combination with marker proteins for the different hair follicle compartments. Immunostaining of such sections for drebrin and hair keratin 6hf, an intermediate filament protein specific for the companion layer (Winter et al, 1998) , showed strong drebrin reactions in the companion layer. In the ORS, drebrin labeling was somewhat weaker (Figs 2A-A 00 , transverse section; Fig 2B, longitudinal section) and depended on the specific type of fixation (see Materials and Methods). By contrast, when hair follicles were double labeled with antibodies against drebrin and keratin 6irs1, a marker protein for the inner root sheath (IRS; Langbein et al, 2002) , a differential distribution of both proteins and absence of drebrin from the IRS was noted (data not shown). The same observation was made for drebrin antibodies in combination with a marker specific for the Huxley layer of the IRS, hair keratin 6irs4 (Fig 2C; Langbein et al, 2003b) . Drebrin and cytokeratin 14, one of the intermediate filament proteins synthesized in the ORS, were found in the same layer but, as expected, in a different localization: Drebrin was accumulated along cell boundaries, whereas cytokeratin 14 was positive throughout the cytoplasm (Fig 2D) .
Immunolocalization of drebrin in epithelial skin tumors
As the gene expression patterns of several junction-associated proteins are modified in skin tumors, our next aim was to examine the distribution of drebrin in such tumors and in precancerous lesions. Sections of frozen and paraffinembedded BCC, SCC, keratoacanthomas, and precursor lesions such as actinic keratoses were systematically examined, using drebrin-specific antibodies (Table I) . In BCC, intense drebrin reactivity was observed in all specimens examined (Fig 3A) . This conspicuously positive reaction was seen throughout the entire tumor on formaldehyde-fixed cryostat sections and paraffin-embedded tissues. On cryostat sections fixed with acetone, the carcinoma cells located at the periphery of the BCC sometimes appeared enhanced, whereas reactions within the tumors were slightly weaker (not shown).
In contrast to the strong and near-homogeneous drebrin immunostaining of BCC, the drebrin distribution appeared to be mostly inhomogeneous in SCC: usually, rather intense drebrin reactions were noted along cell borders in certain parts of the tumor, whereas other parts of the same tumor appeared to be negative for drebrin (Fig 3B) . The drebrinpositive tumor regions were mostly found at the invasive tumor front, but sometimes also occurred near horn pearls of differentiated squamous carcinomas, in a distribution that did not display a correlation to the specific degree of differentiation. To examine whether the drebrin-rich cells within an SCC represented the highly proliferative fraction, double immunolabeling was performed with drebrin antibodies in combination with others reactive with the proliferation marker Ki67. Reactions for Ki67 were found in numerous cells at the invasive tumor margins, but the Ki67-positive cells were not identical to the drebrin-positive ones (data not shown).
The same phenomenon as in SCC, i.e. mosaicism of intensely drebrin-positive and drebrin-negative tumor regions, was observed in keratoacanthomas ( Figs 3C, D) . Precancerous lesions such as actinic keratoses showed similar heterogeneity. Here, in some regions, the basal keratinocytes revealed some cell border drebrin staining, whereas other basal regions and the upper epidermal layers remained drebrin-negative (Table I ).
Figure 2
Double-label confocal immunofluorescence microscopy of human hair follicles. Formaldehyde-fixed cryostat sections of hair follicles were stained for drebrin with monoclonal antibody Mx823 (red in A, A 00 , and B-D), in combination with antisera against different hair keratins (green). Both drebrin and hair keratin 6hf (green in A 0 , A 00 , and B) are enriched in the companion layer (A-A 00 , vertical section; B, longitudinal section). In addition, drebrin antibodies react in the outer sheath (ORS) (A, A 00 , and B-D) whereas the Huxley layer of the inner root sheath, labeled by antibodies against hair keratin 6irs4 (green in C), does not present significant amounts of drebrin (C, longitudinal section). In D, co-existence of cytokeratin 14 (green) and drebrin in the ORS is shown. Asterisks in A and A 00 denote drebrin-positive eccrine sweat gland ducts. Scale bars: 100 mm.
Figure 1
Immunolocalization of drebrin in paraffin-embedded sections of normal human skin. Normal human epidermis (bracket in A) contains almost no drebrin, but immunoreactions are seen in the endothelium of small blood vessels (asterisks in A and B). Intense labeling is noted in the ducts of eccrine sweat glands (B), especially along the cell-to-cell borders. In addition, drebrin is enriched along the intercellular junctions of hair follicles, both in the bulb (C) and, in upper parts, in the outer root sheath (D). Phase-contrast micrographs are shown in A 0 -D 0 . A-D, antiserum dreb4.1gp. Scale bars: 25 mm.
To clarify whether drebrin synthesis might be correlated with epidermal hyperproliferation in general, biopsy tissues from patients with psoriasis were immunostained. In all of the psoriasis samples examined, the epidermis was practically devoid of drebrin, indicating that drebrin most likely is not related to hyperproliferation per se. Moreover, none of the seborrheic keratoses examined revealed significant amounts of drebrin (Table I) .
We wondered whether the staining pattern observed here was also applicable for other actin-binding proteins. Therefore, we immunostained sections of human skin and skin tumors with antibodies to ezrin, a protein sharing certain features with drebrin such as a prolin-rich, profilinbinding domain and the tendency to accumulate in actinrich cell protrusions and in the cell cortex (for a review, see Bretscher et al, 2002) . In normal skin, ezrin was enriched at the junctions of keratinocytes in all epidermal layers, in sebaceous glands, eccrine sweat glands, and hair follicles, and also at cell borders in endothelia of small blood vessels (data not shown). Immunostaining of different epithelial skin tumors and precancers showed strong ezrin reactions at cell boundaries and, although weaker, in the cytoplasm of BCC, SCC, keratoacanthomas, and actinic keratoses, homogeneously throughout the lesions (not shown).
Double-immunofluorescence confocal laser scanning and immunoelectron microscopy When cryostat sections of BCC were double stained for drebrin and actin, almost complete co-localization of both proteins along intercellular borders was found (Figs 4A-A 00 ). Double immunostaining with different marker proteins of adhering junction plaques such as a-catenin, b-catenin, and plakoglobin showed a farreaching overlap with drebrin (data not shown). In contrast, the desmosomal plaque protein, desmoplakin, was completely differently distributed, showing the typical punctuate desmosomal arrays whereas drebrin immunostaining displayed a more linear and, in some regions, distinctive interdesmosomal pattern (Figs 4B-B 00 ). When BCC were labeled for proteins of tight junctions such as ZO-1, ZO-2, and occludin, no significant reaction was noted. Claudin-1 was enriched along cell boundaries, but mostly differently distributed from drebrin (not shown; for localization of claudin-1 in SCC, see Langbein et al, 2003a) . With antibodies against the gap junction protein connexin 43 faint, if any, staining and no overlap with drebrin was seen in BCC (see also Tada and Hashimoto, 1997) , whereas keratinocytes in the overlying epidermis displayed intense typical gap junction-like reactions, serving as an internal control (not shown). As other authors have recently observed co-localization and biochemical interaction of drebrin and connexin 43 at gap junctions of astrocytes and Vero cells (Butkevich et al, 2004) , we double immunostained various cultured cells, including primary human keratinocytes, mammary carcinoma cells of line MCF-7, and endothelial human umbilical vein endothelial cells for drebrin and connexin 43 but, again, mutually exclusive localization was noted.
As our double label laser scanning results indicated accumulation of drebrin near adhering junctions, we also performed immunoelectron microscopy (Figs 5B-E). On sections of BCC, immunogold labeling for drebrin was detected in the microfilament network underlying the plaques of adhering junctions, usually close to the plaques, whereas desmosomes were not significantly labeled. For comparison, immunoelectron microscopy with antibodies to b-catenin was performed, which showed a typical junctional plaque reaction, typically closer to the plasma membrane than drebrin (data not shown).
Immunoblot analysis of skin and skin tumors To compare the amounts of drebrin in the skin and in skin tumors, we performed immunoblot analysis of total protein lysates from normal skin (Figs 6A-A 00 , lane 1), scalp (lane 2), BCC (lane 3), squamous carcinomas (lane 4), melanoma metastases (lane 5), and leiomyosarcoma (lane 6). An immunoreactive 120 kDa band corresponding to drebrin was hardly detectable in normal skin and scalp but was drastically increased in all tumors examined. Comparably high amounts of drebrin were found in lysates of BCC, corresponding to our immunostaining results, and in SCC, despite the microscopically observed heterogeneous staining pattern. In contrast to drebrin, the amounts of actin were approximately equal in all samples examined, with the expected exception of the actin-rich leiomyosarcoma (Fig 6A  00 ).
Primary human keratinocytes synthesize drebrin When primary human keratinocytes were analyzed by immunofluorescence microscopy and immunoblotting (Fig 7) , drebrin could be detected in rather high amounts. Drebrin and actin again co-localized along cell-cell boundaries, corresponding to our observations on BCC ( Fig 7A) . Moreover, in subconfluent cultures, numerous actin-rich filopodia were observed at the free margins of the cells but did not reveal drebrin enrichment (data not shown). Immunoblot analysis of total proteins from subconfluent ( Fig 7B, lane 1 ) and confluent (lane 2) keratinocytes showed strong drebrin reactions. Thus, the cell culture conditions appeared to have . When formaldehyde-fixed cryostat sections of BCC have been double labeled for drebrin (mab Mx823, red in A and A 0 ) and actin (phalloidin Alexa 488, green in A and A 00 ), far-reaching co-localization of both proteins in the submembranous actin cortex underlying adhering junctions is seen (A, merge). In contrast, drebrin and desmoplakin antibodies (mab Mx823, red in B and B 0 ; rabbit anti-desmoplakin, green in B and B 00 ) display mutually exclusive localizations, as desmoplakin is restricted to dot-like structures corresponding to desmosomes and drebrin occurs in intermittent structures, representing an alternate pattern (B, merge). Note also the occurrence of some cytoplasmic granular drebrin aggregates (see also Peitsch et al, 1999 Peitsch et al, , 2001 ). Scale bars: 10 mm. induced drebrin synthesis in normally near drebrin-negative keratinocytes.
Generation and analysis of drebrin cDNA-transfected cell lines Currently, the regulation of the formation of actinrich cell processes is discussed as a major function of drebrin (e.g., Shirao, 1995) , whereas not much is known about its functions in relation to adhering junctions. To elucidate such functions, we generated cell lines stably expressing drebrin-EGFP fusion proteins. We chose A431 cells as this was one of the rare cell lines devoid of endogenous drebrin (Fig 8A  0 , lane 2; see also Peitsch et al, 1999 Peitsch et al, , 2001 . Such cells were transfected-transiently and stably-with constructs of drebrin and EGFP (both C-and Nterminal) and with myc-tagged drebrin, with essentially identical results. With all constructs used, some of the transfectants overexpressed drebrin, usually displaying numerous actin-rich cell processes (data not shown; for relevant references, see Introduction). In the transfectants seemingly containing less drebrin, however, the fusion protein was enriched at cell-cell boundaries, and fewer and shorter cell processes were seen (Fig 9, left panel) . For further experiments, stable lines exhibiting the latter phenotype were analyzed. Three such lines (Fig 8A  0 , lanes 3-5) were examined in comparison with non-transfected A431 cells (lane 2) and human astrocytic glioma cells (lane 1) and were found enriched in drebrin, in levels comparable with those in glioma cells.
To test whether the drebrin-EGFP fusion proteins also interacted with actin, as shown for the endogenous protein, lysates from stable transfectants were immunoprecipitated with drebrin antibodies (Fig 8B) . In immunoprecipitates of both drebrin-EGFP-C1 transfectants (lane 4) and of drebrin-EGFP-N1 transfectants (lane 6), two prominent bands were seen: one at approximately 140 kDa in the EGFP-C1 lines or 150 kDa in the EGFP-N1 lines, and the other at approximately 43 kDa. These bands were identified as drebrin and actin by ''peptide finger printing,'' indicative of an actin-drebrin complex (for similar complexes, see also . Four other minor bands were also excised and analyzed by trypsin digestion and matrix-assisted laser desorbtion/ionization (MALDI) and were identified as different myosin isoforms. Compared with drebrin and actin, these bands were much fainter and also appeared, in trace amounts, in control samples. Similar immunoprecipitation results were obtained with antisera dreb254.2 ( Fig 8B) and mab Mx823 (data not shown). As profilin, another actinbinding protein interacting with prolin-rich motifs, has been described as a binding partner for drebrin (Mammoto et al, 1998) , our immunoprecipitates were also immunoblotted for profilin, however, without significant reactions (data not shown).
When A431 cells stably transfected with drebrin-EGFP constructs were immunostained with antibodies and compared with constituent proteins of intercellular junctions, far-reaching co-localization was evident (Fig 9; Table S1 ). Antibodies against plakoglobin (Figs 9A 0 , A 00 ), a protein of the plaques of both adhering junctions and desmosomes , revealed some co-distribution with the drebrin-EGFP fusion proteins but the typical punctate desmosomal structures were drebrin negative. Proteins representing exclusive ''markers'' for adhering junctions such as the plaque proteins b-catenin (Figs 9B 0 , B 00 ), a-catenin, and p120 (not shown) as well as the transmembrane protein E-cadherin (Figs 9C 0 , C 00 ) partially co-localized with drebrin (see merged images in Figs 9B 0 , B 00 ). When cells were labeled for l/s-afadin, however, a junction plaque protein forming complexes with the transmembrane proteins nectin and ponsin (Takai and Nakanishi, 2003) , little if any codistribution with drebrin-EGFP was seen (not shown). Antibodies against desmosomal proteins such as desmoplakin showed punctate staining patterns entirely different from those of the drebrin fusion proteins (not shown). No significant co-localization was seen with protein ZO-1, known to occur both at adhering and at tight junctions.
Other tight junction proteins such as occludin, claudin 1, and ZO-2 were not detected in monolayer cultures of the transfectants. Similarly, no significant reaction was seen for the gap junction protein connexin 43 (not shown). Antibodies against a-actinin (not shown), vinculin (Figs 9D 0 , D 00 ), and vasodilator-stimulated phosphoprotein (VASP) (not shown) reacted predominantly with focal adhesions that were virtually devoid of drebrin-EGFP, as previously reported for endogenous drebrin (Peitsch et al, 1999) .
Taken together, the drebrin-EGFP fusion protein was seen at adhering junctions, together with actin, close to, but mostly not directly at the adherens plaques, corresponding to our observations in situ.
Distribution of drebrin fusion proteins after stimulation with epidermal growth factor (EGF) As drebrin is thought to function as a regulator of cell processes in neurons (e.g., Toda et al, 1999) , we examined whether this protein also accumulates in or at newly forming protrusions. To this end, we took advantage of the fact that A431 cells can rapidly form lamellipodia and filopodia on stimulation with EGF (cf., e.g., Malliri et al, 1998) . When stably drebrin-transfected A431 cells were treated with 100 ng per mL EGF and analyzed by live cell microscopy, rapid formation of lamellipodia was observed within a few minutes (Figs 10B, C; Supplementary Material, Movie 1). Within the next minutes, the lamellipodia retracted ( Figs 10D, E) , and filopodia-like structures appeared (Figs 10F-H) . During this process, the drebrin-EGFP fusion proteins remained for the most part enriched along cell boundaries (Figs 10A 0 -H 0 ; Supplementary Material, Movie 2), and after retraction even showed enhanced fluorescence at these sites (arrows in Figs 10G 0 , H 0 ). In some cells, drebrin-EGFP was, in addition, temporarily enriched in spikes in extended (asterisks in Figs 10B 0 , C 0 ) and retracting lamellipodia (asterisks in Figs 10D 0 , F 0 ). This signal, however, was rather faint compared with the junctional signal, and the filopodia formed after approximately 15 min were virtually free of drebrin. Essentially, the same observations were made when cells treated with EGF for 5-15 min were fixed with formaldehyde, when cells were stimulated with different EGF concentrations, ranging from 10 to 100 ng per mL (not shown), and with EGFP constructs at the N-and the C-terminus of drebrin.
In summary, our observations that drebrin is not accumulated in the filopodia of subconfluent keratinocytes and the live cell microscopy results all indicate that in the epithelial cells examined, drebrin normally functions at junctions, not in filopodia and lamellipodia. Overexpression of drebrin, however, may lead to the formation of cell processes, as previously described for other cells (e.g., Shirao et al, 1992; Keon et al, 2000) .
Discussion
Drebrin in normal and pathologically altered tissues In normal human skin, the epidermis contains very little, if any, drebrin, but this protein is enriched in the ducts of eccrine sweat glands, similar to what has been noted in mammary gland ducts and in distal renal tubules (Peitsch et al, 1999, 2003; Keon et al, 2000) . Moreover, drebrin is accumulated in the ORS and the companion layer of hair follicles, most likely in association with intercellular adhering junctions (zonulae adhaerentes). This distribution pattern appears rather unexpected, as most proteins associated with adhering junctions in hair follicles also occur in one or more epidermal layers and vice versa. Several other junction-associated proteins, however, are known to be specifically synthesized during hair follicle development (review: Jamora and Fuchs, 2002) . Moreover, b-catenin (Gat et al, 1998; Celso et al, 2004) and other plaque proteins of adhering junctions such as a-catenin and plakoglobin have been shown to control hair follicle morphogenesis and cycling (Charpentier et al, 2000; Vasioukhin et al, 2001) , and mutations and deletions in the plakoglobin gene are associated with hair abnormalities (''Naxos disease''; McKoy et al, 2000) . To elucidate whether drebrin might similarly be involved in follicular morphogenesis, we will study hair follicle development, murine hair follicle cycling, and different types of alopecias.
The most remarkable result of our study is the strong increase of drebrin in epithelial skin tumors. In particular, intense and homogeneous immunostaining has been noted in BCC, an intriguing finding in the light of the hypothesis of a follicular derivation of BCC (e.g., Schirren et al, 1997; Jih 4 and 6, arrows) , representing actin. In non-transfected A431 cells, used for immunoprecipitation control (lane 2), the only prominent band is seen at approximately 55 kDa, containing the heavy chains of the immunoglobulins (see also lanes 4 and 6). The proteins bound non-specifically during ''preclearing'' of each lysate have been loaded for control (lanes 1, 3, and 5) . Protein standards in lane M (A, B) correspond to 212, 158, 116, 97, 66 , 55, and 43 kDa (from top to bottom). Krü ger et al, 1999) . Moreover, cytokeratin 6hf, a keratin specific for the companion layer, has been detected in more than 70% of the BCC examined (Kurzen et al, 2001) , in the absence of all other hair keratins (Cribier et al, 2001) . Interestingly, in the hair follicle, this layer is also conspicuous by its drebrin content. A follicular derivation of BCC might explain why BCC are homogeneously drebrin positive, in contrast to the other epithelial skin tumors examined.
Whether the demonstrated reliable detection of drebrin in BCC will be of practical diagnostic use has to be seen. Reasonable diagnostic applications would be the possibility of the detection of early BCC that might otherwise be overlooked and of small nests at the margins of surgical resections. Moreover, it will also have to be examined as to whether high amounts of drebrin occur in other tumors derived from hair follicles such as pilomatrixomas, follicular harmatomas, and pilomatrix carcinomas.
In contrast to BCC, SCC and their precursor lesions as well as keratoacanthomas show surprisingly variable immunoreactions for drebrin and immunostaining mosaicism in the same tumor, without obvious relation to the local degree of differentiation or proliferation. Mosaic patterns within a tumor have also been found for a number of other junctional proteins such as plakophilin 1 (Moll et al, 1997) and desmosomal cadherins (Kurzen et al, 2003) . In a recent study, Langbein et al (2003a) have described tight junction marker proteins defining subregions in SCC. Such data indicate that epithelial skin cancers can comprise multiple small subregions and that such regionalization might contribute to notorious differences of chemoresistency of several SCC.
In general, however, our western blot analyses have shown highly significant drebrin increases in SCC, in levels comparable with those in BCC. Moreover, drebrin has been -D) , the drebrin reaction is predominantly observed along intercellular borders, although some diffuse cytoplasmic staining is also seen. Additionally, some cells form numerous small cell processes, extending to different focal planes (asterisks in A, A 00 , D, and D 00 ). When simultaneous staining is performed with antibodies to the adhering junctionassociated proteins plakoglobin (A 0 ), bcatenin (B 0 ), and E-cadherin (C 0 ), the merge images (A 00 -C 00 ) show partial co-localization with drebrin-EGFP at cell-cell borders, more prominently for b-catenin and E-cadherin than for plakoglobin. Vinculin antibodies react with focal contacts (D 0 ), that do not contain drebrin (D 00 , merge). Scale bars: 20 mm.
found to be markedly increased in melanoma metastases and in leiomyosarcomas. This raises the question as to whether upregulation of drebrin might be an event commonly related to tumorigenesis, which will have to be systematically examined in future studies. In this context, our finding that drebrin is virtually undetectable in biopsy specimens of patients with psoriasis, a hyperproliferative but not tumorigenic skin disorder, might also be considered as a hint in this direction. As to other proteins associated with adhering junctions, b-catenin is widely regarded as a regulator of tumorigenesis (review: Nelson and Nusse, 2004 ; see also Chan et al, 1999; Doglioni et al, 2003; El-Bahrawy et al, 2003) .
Drebrin localization and morphogenic effects in epithelial cells Previously, we have reported (Peitsch et al, 1999) that permanently growing, but non-malignant keratinocytes such as those of line HaCaT contain very little drebrin. That primary keratinocytes (passage 2) show an apparently higher content of drebrin (Fig 7) may reflect an actual transient upregulation because of the adaption to culture conditions. From this study and previous studies on epithelial cells, a good portion of the cellular drebrin appears to enrich at the cytoplasmic side of adhering junctions, in keratinocytes particularly at the numerous small puncta adhaerentia known to harbor a-and b-catenin and to anchor the actin microfilament bundle system (see, e.g., Green et al, 1987; Kaiser et al, 1993; Kü bler and Watt, 1993; Haftek et al, 1996) . Similarly, in our drebrin cDNA transfections of A341 cells, a squamous carcinoma line devoid of endogenous drebrin, the resulting fusion proteins are enriched at adhering junctions and largely remain in this association after stimulation with EGF. By contrast, in cells with an increased drebrin content, such as in transfectants overexpressing the cDNA constructs, an increased portion of drebrin appears away from cell-cell boundaries. In such cells, we have observed the formation of long, neurite-like cell processes, in correspondence with results of other groups in other cell Figure 10 Live cell microscopy of drebrin-enhanced green fluorescent protein (EGFP) transfectants after stimulation with epidermal growth factor (EGF). When drebrin-cDNA-transfected A431 cells are analyzed by live cell microscopy immediately after the addition of EGF, the bright images show rapid formation of lamellipodia (A-C) that are most extended after approximately 4 min (C). In the following minutes, retraction of lamellipodia (D, E) and formation of numerous filopodia-like cell processes (F-H) are observed. During this process, most of the drebrin-EGFP fusion protein retains a junctional localization (A 0 -H 0 ). In some cells, the junctional EGFP signal first seems to decrease slightly (C 0 -E 0 , cells in the lower left) but then, after 20 min, appears to enhance again, in parallel with cell retraction (arrows in G 0 and H 0 ). Some minor amounts of the fusion protein are additionally seen within protruding and retracting lamellipodia, here in streaky structures presumably representing actin spikes (asterisks in B 0 -F 0 ), whereas no significant signals are seen in filopodia. Scale bar: 10 mm.
types (Shirao et al, 1992; Toda et al, 1999) .
Whereas in neuronal cells drebrin is thought to function primarily as a regulator of cell processes, the distribution observed in epithelial cells implicates that here the protein might be involved in the regulation of actin filament attachment to adhering junctions. Moreover, drebrin has also been implicated in cell-substratum adhesions in neuronal (Ikeda et al, 1995) and in endothelial cells (our unpublished results). There is increasing evidence for regulatory interconnections between these pathways (e.g., Kovacs et al, 2002; DeMali and Burridge, 2003) . Taken together with our previous observations and with reports from the literature, the results shown here suggest that drebrin can serve diverse important functions in different cell types, including formation of cell processes, cell-cell, and cell-substratum adhesion and cell migration. Future studies will have to show whether and in what way drebrin also contributes to the special cell migratory and adhesive activities of tumor cells.
Materials and Methods
Cell cultures Human vulvar squamous carcinoma cells of line A431 American Type Culture Collection (Manassas, Virginia) were grown in Dulbecco's Minimal Essential Medium (DMEM; Invitrogen, Karlsruhe, Germany) supplemented with 10% fetal calf serum (Biochrom, Berlin, Germany) plus 2 mM glutamine, and were subdivided twice weekly at a 1:10 ratio. For stimulation with EGF (Sigma, Deisenhofen, Germany), cells were fed with serum-free medium and, after 2 d, EGF was added in concentrations between 10 and 100 ng per mL. Stimulated cells and non-stimulated controls were further analyzed 0-25 min after stimulation. Primary human keratinocytes were grown using Keratinocyte Growth Medium 2 Kit (PromoCell, Heidelberg, Germany) at normal calcium concentration (1.5 mM CaCl 2 ). Cells were subcultured once per week at a 1:3 ratio, and experiments were conducted mostly after the second passage. The medical ethical committee of the Medical Center Mannheim, University of Heidelberg, approved all described studies. The study was conducted according to the Declaration of Helsinki Principles.
Cloning of drebrin-EGFP constructs and myc-tagged constructs The full-length cDNA encoding drebrin E2 (IMAGE ID: 3356428) was obtained from Resource Center/Primary Database (RZPD, clone ID: IMAGp958A05162, in a pOTB7 vector). For cloning into vector pEGFP-C1 (BD Biosciences Clontech, Palo Alto, California), a Bgl II restriction site was generated by PCR at the Nterminus of the drebrin E2 sequence (forward primer: 5 0 -TTT AGA TCT GCC GGC GTC AGC TTC AGC GGC-3 0 ; reverse primer: 5 0 -CGC ACT TGC GGG CAT CAG). The drebin cDNA was cloned into the Bgl II and Bln I sites of the pEGFP-C1 vector.
For cloning into vector pEGFP-N1 (BD Biosciences Clontech), a Bam H1 restriction site at the C-terminus of the drebrin sequence was created by PCR using a reverse primer containing both an Xho I and a Bam HI site (forward primer: 5 0 -GGT ACT TCA GTC AAT CAC AGG-3 0 ; reverse primer: 5 0 -TTT CTC GAG GAT CCT CAC CAC CCT CGA AGC CCT CCT C-3 0 ), followed by Sac I/Xho I disgestion. Cloning into the pEGFP-N1 vector was performed using Eco RI and Bam H1 sites.
To generate a myc-tagged drebrin construct, a purified, Hind III/ Eco R1 digested myc-tag was cloned into the HindIII and EcoR1 sites of vector pcDNA3.1 (Invitrogen). An EcoR1 restriction site at the N-terminus of the drebrin sequence was generated by PCR on the drebrin-pOTB vector (forward primer: 5 0 -AAG AAT TCA ATG GCC GGC GTC AGC TTC AGC-3 0 ; reverse primer: 5 0 -CGC ACT TGC GGG CAT CAG GCA CAT-3 0 ). The drebrin sequence was subsequently cloned into the pcDNA3.1 vector containing the myctag with Eco RI and Xho I restriction. All PCR products were verified by DNA sequencing.
Transient and stable transfection of A431 cells Cultured A431 vulvar carcinoma cells were transiently transfected with drebrinpEGFP-C1, -N1, and myc-tagged constructs at cell densities of 70%-90%, using lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. To generate stable lines, A431 cells transfected with drebrin-pEGFP-C1 and -N1 were seeded on 10 cm-culture dishes at a 1:100 dilution and selected with 1.2 mg per mL geniticin (Invitrogen). Geneticin-resistant colonies were picked with 3 mm-cloning discs (Sigma) and transferred first into 24-well microtiter plates, and then into 2 cm-culture dishes. Drebrin-positive clones were selected according to EGFP fluorescence and by immunoblot analysis of total protein lysates. Stably transfected A431 lines were maintained in DMEM supplemented with 10% fetal calf serum, 2 mM glutamine, and 1 mg per mL geniticin.
Tissues Samples of human skin and skin tumors were obtained in the course of routine pathological diagnoses from the Departments of Dermatology and Pathology of the Medical Center Mannheim. For some experiments, samples were snap-frozen in liquid nitrogen at approximately À1301C and stored at À801C. For other experiments, aldehyde-fixed, paraffin-embedded tissues were used. Procedures were performed with patients' informed consent.
Generation of monoclonal and polyclonal antibodies to drebrin For the generation of mab to drebrin, we used a cocktail of three different peptides derived from the amino acid sequence, pep1 (amino acids (aa) 32-44, YTYEDGSDDLKLA), pep3 (aa 487-502, STLQGEPRAPTPPSGT), and pep4 (aa 632-649, CWDADPVPEEEEGFEGGD), all of which were synthesized by Peptide Specialty Laboratories (Heidelberg, Germany). Three 9-wk-old female BALB/c mice were immunized by subcutaneous injections of 100 mg of the peptide cocktail diluted in phosphatebuffered saline (PBS) to a volume of 150 mL, supplemented with 150 mL of complete Freud's adjuvants (Sigma). Three subcutaneous booster injections with the same amount of peptide cocktail mixed with 150 mL incomplete Freud's adjuvant were given at intervals of 21 d. At day 63, a final boost with 30 mg of the peptide cocktail diluted in 200 mL PBS was injected intraperitoneally. Four days thereafter, the mice were sacrificed, spleen cells were harvested and fused with mouse myeloma cells of line SP2/0 at a ratio of 2:1 in the presence of polyethylenglycol 1500 (Roche Diagnostics, Mannheim, Germany). After fusion, the cells were placed on 24-well microtiter plates and cultured in hypoxanthine-aminopterin-thymidine (HAT)-containing RMPI-1640 medium (Invitrogen) supplemented with 10% fetal calf serum (Invitrogen) and 10% Condimed H1 (Roche Diagnostics). Hybridomas were screened by immunofluorescence microscopy on cultured glioma cells (cf. Peitsch et al, 2001 ) and immunoblot reactivity on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)-separated lysates of glioma cells. Positive colonies were subcloned twice by limited dilution in 96-well microtiter plates. After subcloning, hybridomas were weaned off HAT-RMPI into RMPI medium alone and grown in 25 cm 2 flasks or propagated as ascites in Pristanetreated BALB/c mice. Immunoglobulin subclasses were determined and one of the drebrin-specific immunoglobulin G (IgG) mab obtained, Mx823, was further characterized by separate preincubation with the peptides used for immunization at concentrations ranging from 10 to 200 mg per mL in PBS, followed by immunofluorescence microscopy and immunoblot analysis. These experiments provided evidence that mab Mx823 was directed against pep4, located at the drebrin C-terminus.
Mab Mx823 can be applied in immunolabeling of methanol-, acetone-, and formaldehyde-fixed cells and tissues, showing the strongest reactions after formaldehyde fixation (optimal dilution: 1:50), but not on paraffin-embedded tissues. The antibody also efficiently immunoprecipitates drebrin and is now available from Progen Biotechnik (Heidelberg, Germany).
Pep4 was also used for generation of antibodies in guinea-pigs (cf. Peitsch et al, 2001 ). The resulting antiserum dreb4.1gp also reacted well on aldehyde-fixed, paraffin-embedded sections after antigen retrieval. Other drebrin-specific guinea-pig antisera used, i.e., dreb254.2 and drebE2/A.2, the latter being specific for the isoforms drebrin E2 and A, have been previously described (Peitsch et al, 2001 (Peitsch et al, , 2003 .
Other antibodies and reagents For comparison, we also used the murine drebrin mab M2F6 against purified chicken drebrin E, purchased from MoBiTec (Gö ttingen, Germany). Further mab applied in this study were against plakoglobin (clone PG5.1, Progen Biotechnik, and clone 11E4, kindly provided by Dr M. J. Wheelock, University of Nebraska Medical Center, Omaha, Nebraska), desmogleins Dsg 1 and 2 (clone DG3.10; Progen Biotechnik), E-cadherin, proteins p120 ctn , VASP, and Mena (all from BD Biosciences Pharmingen, Heidelberg, Germany), vinculin (clones 11.5 and hvinc-1), ezrin and a-actinin (all from Sigma), actin (clone 2G2), cytokeratin 18 (clone 174.1), and profilin (all from Progen Biotechnik), and Ki67 as proliferation marker (Dianova, Hamburg, Germany).
Rabbit antisera against a-catenin, b-catenin, and l/s-afadin were obtained from Sigma, rabbit antibodies against proteins ZO-1, ZO-2, occludin, claudin-1, and connexin 43 from Zymed Laboratories (San Francisco, California), and rabbit antibodies against desmoplakin from NatuTec (Frankfurt/Main, Germany). Guinea-pig antisera against cytokeratin 14 or the hair keratins 6hf, 6irs1, and 6irs4 were kindly provided by Dr Lutz Langbein (Division of Cell Biology, German Cancer Research Center, Heidelberg, Germany; cf. Winter et al, 1998; Langbein et al, 2002 Langbein et al, , 2003b . Actin microfilaments were stained with phalloidin coupled to Alexa 488 (MoBiTec) or TRITC-labeled phalloidin (Sigma).
For immunofluorescence microscopy, primary antibody complexes were visualized with secondary antibodies coupled to Cy-3 (Dianova) or Alexa 488 (MoBiTec). For immunoblot analysis, horseradish peroxidase-conjugated secondary antibodies were applied in combination with the enhanced chemiluminescence system (NEN, Kö ln, Germany).
Immunofluorescence and confocal laser scanning microscopy Cultured cells grown on glass coverslips were fixed in 2% formaldehyde for 20 min at room temperature (RT) and treated with 50 mM NH 4 Cl for blocking of free aldehyde groups (5 min, RT), followed by one wash in PBS and by permeabilization in 0.1% Triton X-100 for 3 min (RT). Alternatively, fixation was performed with methanol (À201C, 5 min) and acetone (À201C, 20 s). Frozen tissues were sectioned at 4-5 mm thickness, using a Leica cryomicrotome (Bensheim, Germany), air-dried and fixed with 2% formaldehyde or, alternatively, with acetone (À201C, 10 min). Prior to immunostaining, sections were blocked with 5% goat serum for 20 min. For sectioning of paraffin-embedded tissues (3-4 mm), a Jung Histoslide 2000R cryomicrotome (Leica) was used. After deparaffinization according to standard techniques, sections were pre-treated by microwaving in 100 mM TRIS buffer containing 5% urea (pH 9.5, 10 min, 981C) to achieve heat-induced antigen retrieval. Sections were then washed with PBS (5 min, RT), incubated with PBS containing 2% milk powder (Carl Roth, Karlsruhe, Germany) for 10 min, and blocked with 10% goat serum and 2% milk powder in PBS (15 min). Immunostaining, immunofluorescence microscopy, and confocal laser scanning microscopy were performed as described (Peitsch et al, 2001) , using an Axiophote II photomicroscope (Carl Zeiss, Jena, Germany) for immunofluorescence microscopy and a Zeiss LSM 510 UV microscope for confocal microscopy.
Live cell microscopy Live cell microscopy was carried out on A431 cells stably transfected with drebrin-EGFP-C1 and -N1 constructs, grown on plastic dishes in small colonies for 1 d. Time lapse images were taken at intervals of 30 s for a maximal period of 30 min, using a Zeiss Axiovert S100 TV microscope with an Openlab 3.1.7 alias software.
Electron and immunoelectron microscopy Conventional electron microscopic analysis of samples of BCC was performed according to the protocol described in Peitsch et al (2003) . For immunoelectron microscopy, cryostat sections of BCC of 4-5 mm thickness were fixed with 2% formaldehyde for 10 min (RT), followed by treatment with 50 mM NH 4 Cl (5 min) and permeabilization with 0.1% saponin (5 min). Staining and embedding were as previously reported (Peitsch et al, 2003) . Primary antibodies were Mx823 (1:50) and the rabbit antiserum to b-catenin, secondary antibodies anti-mouse, or anti-rabbit immunoglobulins conjugated with 1.4 nm-gold particles (Nanogold; Biotrend, Kö ln, Germany). Silver enhancement was performed for 5 min with a silver enhancement kit from Nanoprobes (Stony Brooks, New York, New York). Electron micrographs were taken with an EM 900 elecron microscope (LEO, Oberkochen, Germany) at 80 kV.
Immunoblotting, immunoprecipitation, and MALDI analysis Immunoblot analysis of lysates of cultured cells and tissues was performed as previously described (Peitsch et al, 1999) . For immunoprecipitation, cultured cells were washed twice with precooled PBS, lysed in IP buffer (0.1% NP-40, 150 mM sodium chloride, and 20 mM N-2-hydroxyethylpoperazine-N-2-ethanesulfonic acid, pH 7.4, supplemented with Complete Mini inhibitor tabs, EDTA free, from Roche Diagnostics) for 1 h on ice and were mechanically homogenized. After centrifugation for 10 min at 14,000 rpm (41C), the supernatants were ''precleared'' by incubation with protein A-coupled dynabeads or pan-mouse-IgG-coupled dynabeads (Dynal Biotech, Hamburg, Germany) for 2-3 h (41C). Immunoprecipitation of drebrin was performed overnight, using either protein A-dynabeads preincubated with the drebrin antisera dreb254.2 or drebE2/A.2 diluted in a 50 mM TRIS buffer (pH 7.5) or pan-mouse-IgG-dynabeads preincubated with mab Mx823 in TRIS buffer. The immunoprecipitates were washed five times in IP-buffer, solubilized in thrice concentrated Laemmli sample buffer (Peitsch et al, 1999) , boiled for 3 min at 951C, and subjected to SDS-PAGE. The precipitates obtained after preclearing, containing the non-specifically bound proteins, were treated identically and used as controls. Some of the electrophoretically separated probes were transferred onto polyvinylidene difluoride membranes and analyzed by immunoblotting. Others were stained with Coomassie Brilliant Blue; the bands were excised and processed for ''peptide finger printing.'' Trypsin digestion and MALDI analysis were performed in cooperation with Dr M. Schnö lzer (Protein Analysis Facility, German Cancer Research Center), as described (Peitsch et al, 1999) .
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